Alzheimer's disease as a disorder of dynamic brain self-organization

Progress in Brain Research

Volumn 147, Issue SPEC. ISS., 2005, Pages 355-378

  Arendt, Thomas ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PROTEIN P21; RAS PROTEIN;

ALZHEIMER DISEASE; BRAIN DYSFUNCTION; BRAIN FUNCTION; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; COGNITION; CONSCIOUSNESS; DISEASE COURSE; EMOTION; ENVIRONMENTAL FACTOR; EPIGENETICS; EXPERIENCE; HUMAN; LEARNING; MEMORY; MITOGENESIS; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; ONTOGENY; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SELF CONCEPT; SIGNAL TRANSDUCTION; TISSUE REPAIR;

EID: 9644262551     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(04)47025-3     Document Type: Review

References (161)

1. Arendt Th. Neuronal dedifferentiation and degeneration in Alzheimer's disease. Biol. Chem. Hoppe-Seyler. 374:1993;911-912
2. Arendt Th. Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain. Neurobiol. Aging. 21:2000;783-796
3. Arendt Th. Alzheimer's disease as a disorder of mechanisms underlaying structural brain self-organization. Commentary. Neuroscience. 102:2001;723-765
4. Arendt Th. Synaptic plasticity and cell activation in neurons are alternative effector pathways. Progr. Neurobiol. :2003;. (in press)
5. Arendt Th., Bigl V., Arendt A., Tennstedt A. Loss of neurons in the nucleus basalis of meynert in Alzheimer's disease, paralysis agitans and korsakoff 's disease. Acta Neuropathol. 61:1983;101-108
6. Arendt Th., Brückner M.K. Perisomatic sprouts immunoreactive for nerve growth factor receptor and neurofibrillary degeneration affect different neuronal populations in the basal nucleus in patients with Alzheimer's disease. Neurosci. Lett. 148:1992;63-66
7. Arendt Th., Brückner M.K., Lange M., Bigl V. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development. Neurochem. Int. 21:1992;381-396
8. Arendt Th., Brückner M.K., Bigl V., Marcova L. Dendritic reorganization in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease. J. Comp. Neurol. 351:1995a;189-222
9. Arendt Th., Brückner M.K., Bigl V., Marcova L. Dendritic reorganization in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared to other subcortical areas. J. Comp. Neurol. 351:1995b;223-246
10. Arendt Th., Brückner M.K., Gertz H.J., Marcova L. Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurones that retain their capacity of plastic remodelling in the adult brain. Neuroscience. 83:1998;991-1002
11. Arendt Th., Holzer M., Fruth R., Brückner M.K., Gärtner U. Paired helical filament-like phosphorylation of tau, deposition of β/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A. Neuroscience. 69:1995c;691-698
12. Arendt Th., Holzer M., Grossmann A., Zedlick D., Brückner M.K. Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease. Neuroscience. 68:1995d;5-18
13. Arendt Th., Holzer M., Fruth R., Brückner M.K., Gärtner U. Phosphorylation of tau, Aβ-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A. Neurobiol. Aging. 19:1998a;3-13
14. Arendt Th., Holzer M., Gärtner U. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease. J. Neural Transm. 105:1998b;949-960
15. Arendt Th., Holzer M., Gärtner U., Brückner M.K. Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease. J. Neural Trans., Suppl. 54:1998c;147-158
16. Arendt Th., Holzer M., Stöbe A., Gärtner U., Lüth H.-J., Brückner M.K., Ueberham U. Activated mitogenic signalling induces a process of de-differentiation in Alzheimer's disease that eventually results in cell death. Ann. N.Y. Acad. Sci. 920:2000;249-255
17. Arendt Th., Rödel L., Gärtner U., Holzer M. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. NeuroReport. 7:1996;3047-3049
18. Arendt Th., Zvegintseva H.G., Leontovich T.A. Dendritic changes in the basal nucleus of Meynert and in the diagonal band nucleus in Alzheimer's disease - A quantitative Golgi investigation. Neuroscience. 19:1986;1265-1278
19. Arnold S.E., Hyman B.T., Flory J., Damasio A.R., Van Hoesen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex. 1:1991;103-116
20. Arriagada P.V., Growdon J.H., Hedley-White E.T., Hyman B.T. Neurofibrillary tangles but not senlie plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:1992;631-639
21. Barnes C.A. Normal aging: regionally specific changes in hippocampal synaptic transmission. TINS. 17:1994;13-18
22. Benowitz L.I., Routtenberg A. GAP-43: an intrinsic determinant of neuronal development and plasticity. TINS. 20:1997;84-91
23. Bertoni-Freddari C., Fattoretti P., Casoli T., Meier-Ruge W., Ulrich J. Morphological adaptive response of the synaptic junctional zones in the human dentate gyrus during aging and Alzheimer's disease. Brain Res. 517:1990;69-75
24. Bibb J.A., Snyder G.L., Nishi A., Yan Z., Meijer L., Fienberg A.A., Tsai L.-H., Kwon Y.T., Girault J.-A., Czernik A.J., Huganir R.L., Hemmings H.C. Jr., Nairn A.C., Greengard P. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling neurons. Nature. 402:1999;669-671
25. Bondareff W., Mountjoy C.Q., Roth M., Hauser D.L. Neurofibrillary degeneration and neuronal loss in Alzheimer's disease. Neurobiol. Aging. 10:1989;709-715
26. Borasio G.D., John J., Wittinghofer A., Barde Y.A., Sendtner M., Heumann R. Ras p21 protein promotes survival and fiber outgrowth of cultured embryonic neurons. Neuron. 2:1989;1087-1096
27. Boulton T.G., Nye S.H., Robbins D.J., Ip N.Y., Radziejewska E., Morgenbesser S.D., DePinho R.A., Panayotatos N., Cobb M.H., Yancopoulos G.D. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell. 65:1991;663-675
28. Boulton T.G., Yancopoulos G.D., Gregory J.S., Slaughter C., Moomaw C., Hsu J., Cobb M.H. An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control. Science. 249:1990;64-67
29. Braak H., Braak E. On areas of transition between entorhinal allocortex and temporal isocortex in the human brain-normal morphology and lamina-specific pathology in Alzheimer's disease. Acta Neuropathol. 68:1985;325-332
30. Braak H., Braak E. Ratio of pyramidal cells versus non-pyramidal cells in the human frontal isocortex and changes in ratio with ageing and Alzheimer's disease. Prog. Brain Res. 70:1987;185-212
31. Braak H., Braak E. Neuropathological staging of Alzheimer related changes. Acta Neuropathol. 82:1991;239-259
32. Braak H., Braak E. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol. 92:1996;197-201
33. Bramblett G.T., Goedert M., Jakes R., Merrick S.E., Trojanowski J.Q., Lee V.M. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron. 10:1993;1089-1099
34. Buell S.J., Coleman P.D. Dendritic growth in the aged human brain and failure of growth in senile dementia. Science. 206:1979;854-856
35. Buonomano D.V., Merzenich M.M. Cortical plasticity: from synapses to maps. Ann. Rev. Neuroscience. 21:1998;149-186
36. Busser J., Geldmacher D.S., Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J. Neurosci. 18:1998;2801-2807
37. Caldas C., Hahn S.A., da Costa L.T., Redston M.S., Schutte M., Seymour A.B., Weinstein C.L., Hruban R.H., Yeo C.J., Kern S.E. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet. 8:1994;27-32
38. Chapman B. Necessity for afferent activity to maintain eye-specific segregation in ferret lateral geniculate nucleus. Science. 287:2000;2479-2482
39. Cole M.G., Dastoor D.P., Koszycki D. The hierarchic dementia scale. J. Clin. Exp. Geront. 5:1983;219-234
40. Cosgaya J.M., Latasa M.J., Pascual A. Nerve growth factor and ras regulate β-amyloid precursor protein gene expression in PC12 cells. J. Neurochem. 67:1996;98-104
41. Cotman C.W., Geddes J.W., Kahle J.S. Axon sprouting in the rodent and Alzheimer's disease brain: a reactivation of developmental mechanisms? Prog. Brain Res. 83:1990;427-434
42. Cotman C.W., Hailer N.P., Pfister K.K., Soltesz I., Schachner M. Cell adhesion molecules in neural plasticity and pathology: similar mechanisms, distinct organizations? Prog. Neurobiol. 55:1998;659-669
43. Dawson T.M., Snyder S.H. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurosci. 14:1994;5147-5159
44. DeCarli C., Atack J.R., Ball M.J., Kay J.A., Grady L.C., Fewster P., Pettigrew K.D., Rapoport S.I., Schapiro M.B. Post-mortem regional neurofibrillary tangle densities but not senile plaque densities are related to regional cerebral metabolic rates for glucose during life in Alzheimer's disease patients. Neurodegen. 1:1992;113-121
45. Desdouits-Magnen J., Desdouits F., Takeda S., Syu L.J., Saltiel A.R., Buxbaum J.D., Czernik A.J., Nairn A.C., Greengard P. Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascade. J. Neurochem. 70:1998;524-530
46. Drewes G., Lichtenberg-Kraag B., Doring F., Mandelkow E.M., Biernat J., Goris J., Doree M., Mandelkow E. Mitogen Activated Protein (Map) Kinase Transforms Tau-Protein into an Alzheimer-like state. EMBO J. 11:1992;2131-2138
47. Ernfors P., Lindefors N., Chan-Palay V., Persson H. Cholinergic neurons of the nucleus basalis express elevated levels of nerve growth factor receptor mRNA in senile dementia of the Alzheimer type. Dementia. 1:1990;138-145
48. Esclaire F., Terro F., Yardin C., Hugon J. Neuronal apoptosis is associated with a decrease in tau mRNA expression. NeuroReport. 9:1998;1173-1177
49. Ferrari G., Greene L.A. Proliferative inhibition by dominant-negative Ras rescues naive and neuronally differentiated PC12 cells from apoptotic death. EMBO J. 13:1994;5922-5928
50. Ferrer I., Aymami A., Rovira A., Grau Veciana J.M. Growth of abnormal neurites in atypical Alzheimer's disease. A study with the Golgi method. Acta Neuropathol. (Berl.). 59:1983;167-170
51. Fischer O. Miliare Necrosen mit drusigen Wucherungen der Neurofibrillen, eine regelmässige Veränderung der Hirnrinde bei seniler Demenz. Monatsschrift für Psychiatrie und Neurologie. 22:1907;361-372
52. Flechsig P. Ueber die entwickelungsgeschichtliche (myelogenetische) Flächengliederung der Grosshirnrinde des Menschen. Archives Italiennes de Biologie. 36:1901;30-39
53. Freeman R.S., Estus S., Johnson E.M. Analysis of cell cycle related gene expression in postmitotic neurons. Selective induction of cyclin D1 during programmed cell death. Neuron. 12:1994;343-355
54. Gärtner U., Holzer M., Arendt Th. Neurofibrillary lesions in Alzheimer's disease are associated with 14-3-3 protein. Biol.Chem. 377:(Spec.Suppl.):1996;S180
55. ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration. Neuroscience. 91:1999;1-5
56. ras in Alzheimer pathology. NeuroReport. 6:1995;1441-1444
57. Gansauge S., Nussler A.K., Berger H.G., Gansauge F. Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and increase of the cyclin-dependent kinase inhibitor p21WAF1/CIP1. Cell Growth Differ. 9:1998;611-617
58. Geddes J.W., Wong J., Choi B.H., Kim R.C., Cotman C.W., Miller F.D. Increased expression of the embryonic form of a developmentally regulated mRNA in Alzheimer's disease. Neurosci. Lett. 109:1990;54-61
59. Gibson P.H. EM study of the numbers of cortical synapses in the brains of ageing people and people with Alzheimer-type dementia. Acta Neuropathol. (Berl.). 62:1983;127-133
60. Goedert M., Cohen E.S., Jakes R., Cohen P. p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1 - implication for Alzheimer's disease. FEBS Lett. 312:1992;95-99
61. Goedert M., Jakes R., Crowther R.A., Six J., Lubke U., Vandermeeren M., Cras P., Trojanowski J.Q., Lee V.M. The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc. Natl. Acad. Sci. USA. 90:1993;5066-5070
62. Goedert M., Spillantini M.G., Cairns N.J., Crowther R.A. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron. 8:1992a;159-168
63. Goldman-Rakic P.S., Isseroff A., Schwartz M.L., Bugbee N.M. The neurobiology of congnitive development. In Mussen P.H. (Eds.), Handbook of Child Psychology 4th, Infancy and Developmental Psychobiology. M.M. Haith and J.J. Campos. 2:1988;281-344
64. Gong C.X., Singh T.J., Grundke-Iqbal I., Iqbal K. Phosphoprotein phosphatase-activities in Alzheimer's disease brain. J. Neurochem. 61:1993;921-927
65. Greenberg S.M., Koo E.H., Selkoe J., Qiu W.Q., Kosik K.S. Secreted beta amyloid precursor protein stimulates mitogen activated protein kinase and enhances tau phosphorylation. Proc. Natl. Acad. Sci. USA. 91:1994;7104-7108
66. Hasegawa M., Arai T., Ihara Y. Immunochemical evidence that fragments of phosphorylated MAP5 (MAP1B) are bound to neurofibrillary tangles in Alzheimer's disease. Neuron. 4:1990;909-918
67. Haxby J.V., Grady C.L., Koss E., Horwitz B., Heston L., Schapiro M., Friedland R.P., Rapoport S.I. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch. Neurol. 47:1990;753-760
68. Heintz N. Cell-Death and the Cell-Cycle - A relationship between transformation and neurodegeneration. Trends in Biochem. Sci. 18:1993;157-159
69. Hess D.T., Patterson S.I., Smith D.S., Skene J.H. Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature. 366:1993;562-565
70. Hindley S., Juurlink B.H., Gysbers J.W., Middlemiss P.J., Herman M.A., Rathbone M.P. Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism. J. Neurosci. 15:1997;427-439
71. Hirano A., Zimmerman H.M. Alzheimer's neurofibrillary changes-A topographic study. Arch. Neurol. 7:1962;227-242
72. Hof P.R., Bouras C., Perl D.P., Sparks D.L., Mehta N., Morrison J.H. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Arch. Neurol. 52:1995;379-391
73. Hofman M.A. Encephalization in hominids: evidence for the model of punctuationalism. Brain Behav. Evol. 22:1983;102-117
74. Horn D., Ruppin E. Compensatory mechanisms in an attractor neural network model of schizophrenia. Neural Comput. 7:1995;182-205
75. Hubel D.H., Wiesel T.N. Binocular interaction in striate cortex of kittens reared with artificial squint. J. Neurophysiol. 28:1965;1041-1059
76. Ihara Y. Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease. Brain Res. 459:1988;138-144
77. Ishida A., Sasaguri T., Kosaka C., Nojima H., Ogata J. Induction of the cyclin-dependent kinase inhibitor p21 (Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells. J. Biol. Chem. 272:1997;10050-10057
78. Jorgensen O.S., Balázs R. Plastic neuronal changes in Alzheimer's disease associated with activation of astrocytes and enhanced neurotrophic activity. Corain B., Iqbal K., Nicolini M., Winblad B., Wisniewski H., Zatta P. Alzheimer's Disease: Advances in Clinical and Basic Research. 1993;189-198 Wiley, Chichester
79. Kamb A., Gruis N.A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S.V., Stockert E., Day R.S. 3rd, Johnson B.E., Skolnick M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264:1994;436-440
80. Kanemaru K., Takio K., Miura R., Titani K., Ihara Y. Fetal-type phosphorylation of the tau in paired helical filaments. J. Neurochem. 58:1992;1667-1675
81. Knowles R.B., Wyart C., Buldyrev S.V., Cruz L., Urbanc B., Hasselmo M.E., Stanley H.E., Hyman B.T. Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 96:1999;5274-5279
82. Kobayashi S., Ishiguro K., Omori A., Takamatsu M., Arioka M., Imahori K., Uchida T. A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule. FEBS Lett. 335:1993;171-175
83. Kondratick C.M., Vandré D.D. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes. J Neurochem. 67:1996;2405-2416
84. Kosik K.S. The neuritic dystrophy of Alzheimer's disease: degeneration or regeneration? Hefti F., Brachet P., Will B., Christen Y. Growth Factors and Alzheimer's Disease. 1991;234-240 Springer-Verlag, New York
85. Kranenburg O., van der Eb A., Zantema A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J. 15:1996;46-54
86. Kuzin B., Roberts I., Peunova N., Enikolopov G. Nitric oxide regulates cell proloferation during Drosophila development. Cell. 87:1996;639-649
87. Lander H.M., Hajjar D.P., Hempstead B.L., Mirza U.A., Chait B.T., Campbell S., Quilliam L.A. A molecular redox switch on p21 (ras). Structural basis for the nitric oxide-p21 (ras) interaction. J. Biol. Chem. 272:1997;4323-4326
88. Lander H.M., Jacivina A.T., Davis R.J., Tauras J.M. Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J. Biol. Chem. 271:1996;19705-19709
89. Lassmann H., Weiler R., Fischer P., Bancher C., Jellinger K., Floor E., Danielczyk W., Seitelberger F., Winkler H. Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles. Neuroscience. 46:1992;1-8
90. Ledesma M.D., Correas I., Avila J., Diaznido J. Implication of Brain Cdc2 and Map2 Kinases in the Phosphorylation of Tau Protein in Alzheimers-Disease. FEBS Lett. 308:1992;218-224
91. Lendvai B., Stern E.A., Chen B., Svoboda K. Experience-dependent plasticity of dendritic spines in the developing rat barrel cortex in vivo. Nature. 404:2000;876-881
92. Lesort M., Blanchard C., Yardin C., Esclaire F., Hugon J. Cultured neurons expressing phosphorylated tau are more resistant to apoptosis induced by NMDA or serum deprivation. Mol. Brain Res. 45:1997;127-132
93. Lewis D.A., Campbell M.J., Terry R.D., Morrison J.H. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J. Neuroscience. 7:1987;1799-1808
94. Liu W., Bi X.N., Tocco G., Baudry M., Schreiber S.S. Increased expression of cyclin D1 in the adult rat brain following kainic acid treatment. NeuroReport. 7:1996;2785-2789
95. INK4a. Brain Res. 852:2000;45-55
96. McEachern J.C., Shaw C.A. An alternative to the LTP orthodoxy: a plasticity-pathology continuum model. Brain Res. Rev. 22:1996;51-92
97. McGeer P.L., McGeer E.G., Akiyama H., Itagaki S., Harrop R., Peppard R. Neuronal degeneration and memory loss in Alzheimer's disease and aging. Exp. Brain Res. 21:1990;411-426
98. McKee A.C., Kowall N.W., Kosik K.S. Microtubular reorganization and dendritic growth response in Alzheimer's disease. Ann Neurol. 26:1989;652-659
99. McShea A., Harris P.L., Webster K.R., Wahl A.F., Smith M.A. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am. J. Pathol. 150:1997;1933-1939
100. Mandelkow E.M., Drewes G., Biernat J., Gustke N., Vanlint J., Vandenheede J.R., Mandelkow E. Glycogen-Synthase Kinase-3 and the Alzheimer-Like State of Microtubule-Associated Protein Tau. FEBS Lett. 314:1992;315-321
101. Martin L.J., Pardo C.A., Cork L.C., Price D.L. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol. 145:1994;1358-1381
102. Masliah E. Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol. Histopathol. 10:1995;509-519
103. Masliah E., Miller A., Terry R.D. The synaptic organization of the neocortex in Alzheimer's disease. Med. Hypotheses. 41:1993;334-340
104. Masliah E., Terry R. The role of synaptic proteins in the pathogenesis of disorders of the central nervous system. Brain Pathol. 3:1993;77-85
105. Mikkonen M., Soininen H., Tapiola T., Alafuzoff I., Miettinen R. Hippocampal plasticity in Alzheimer's disease: changes in highly polysialylated NCAM immunoreactivity in the hippocampal formation. Eur. J. Neurosci. 11:1999;1754-1764
106. Mills J., Charest D.L., Lam F., Beyreuther K., Ida N., Pelech S.L., Reiner P.B. Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway. J. Neurosci. 17:1997;9415-9422
107. Mills J.C., Lee V.M.Y., Pittman R.N. Activation of a PP2A-like phosphatase and dephosphorylation of τ protein characterize onset of the execution phase of apoptosis. J. Cell Sci. 111:1998;625-636
108. Morrison D. 14-3-3: modulators of signaling proteins? Science. 266:1994;56-57
109. Mufson E.J., Kordower J.H. Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 89:1992;569-573
110. Mukaetova-Ladinska E.B., Garcia-Siera F., Hurt J., Gertz H.J., Xuereb J.H., Hills R., Brayne C., Huppert F.A., Paykel E.S., McGee M., Jakes R., Honer W.G., Harrington C.R., Wischik C.M. Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. Am. J. Pathol. 157:2000;623-636
111. Nagy Z.S., Esiri M.M. Apoptosis-related protein expression in the hippocampus in Alzheimer's disease. Neurobiol. Aging. 18:1997;565-571
112. Nagy Z., Esiri M.M., Cato A.M., Smith A.D. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol. 94:1997;6-15
113. Nagy Z., Esiri M.M., Smith A.D. The cell division cycle and the pathophysiology of Alzheimer's disease. Neuroscience. 87:1998;731-739
114. Neve R.L., Finch E.A., Bird E.D., Benowitz L.I. Growth-associated protein GAP-43 is expressed selectively in associative regions of the adult human brain. Proc. Natl. Acad. Sci. USA. 85:1988;3638-3642
115. Nothias F., Fischer I., Murray M., Mirman S., Vincent J.-D. Expression of a phosphorylated isoform of MAP1B is maintained in adult central nervous system areas that retain capacity for structural plasticity. J. Comp. Neur. 368:1996;317-334
116. Patrick G.N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P., Tsai Li.-H. Conversion of p35 to 25 deregulates Cdk5 activity and promotes neurodegeneration. Nature. 402:1999;615-622
117. Paula-Barbosa M.M., Cardoso R.M., Guimaraes M.L., Cruz C. Dendritic degeneration and regrowth in the cerebral cortex of patients with Alzheimer's disease. J. Neurol. Sci. 45:1980;129-134
118. Pearson R.C.A., Esiri M.M., Hiorns R.W., Wilcock G.K., Powell T.P.S. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 82:1985;4531-4534
119. Peunova N., Enikolopov G. Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells. Nature. 364:1993;450-453
120. Peunova N., Enikolopov G. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature. 375:1995;68-73
121. Pfenninger K.H., de la Houssaye B.A., Helmke S.M., Quiroga S. Growth-regulated proteins and neuronal plasticity. A commentary. Mol. Neurobiol. 5:1991;143-151
122. Phillips L.L., Belardo E.T. Increase of c-fos and ras oncoproteins in the denervated neuropil of the rat dentate gyrus. Neuroscience. 58:1994;503-514
123. Piaget J. The Origins of Intelligence in Children. :1952;Routledge & Kegan Paul, London
124. Poluha W., Schonhoff C.M., Harrington K.S., Lachyankar M.B., Crosbie N.E., Bulseco D.A., Ross A.H.A. A novel, nerve growth factor-activated pathway involving nitric oxide, p53, and p21WAF1 regulates neuronal differentiation of PC12 cells. J. Biol. Chem. 272:1997;2002-2007
125. Pope W.B., Lambert M.P., Leypold B., Seupaul R., Sletten L., Krafft G., Klein W.L. Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y. Exp. Neurol. 126:1994;185-194
126. Preuss U., Doring F., Illenberger S., Mandelkow E.M. Cell cycle-dependent phosphorylation and microtubule binding of tau protein stably transfected into Chinese hamster ovary cells. Mol. Biol. Cell. 6:1995;1397-1410
127. Probst A., Basler V., Bron B., Ulrich J. Neuritic plaques in senile dementia of Alzheimer type: a Golgi analysis in the hippocampal region. Brain Res. 268:1983;249-254
128. Rapoport S.I. In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer's disease. Eur. Arch. Psychiatry Clin. Neurosci. 249:(Suppl 3):1999;46-55
129. Reisberg B., Ferris S.H., de Leon M.J., Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatry. 139:1982;1136-1139
130. Reisberg B., Franssen E.H., Hasan S.M., Monteiro I., Boksay I., Souren L.E., Kenowsky S., Auer S.R., Elahi S., Kluger A. Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer's and other dementing processes. Eur. Arch. Psychiatry Clin. Neurosci., 249, Suppl. 3:1999a;28-36
131. Reisberg B., Kenowsky S., Franssen E.H., Auer S.R., Souren L.E. Towards a science of Alzheimer's disease management: a model based upon current knowledge of retrogenesis. Int. Psychogeriatr. 11:1999b;7-23
132. Saitoh T., Horsburgh K., Masliah E. Hyperactivation of signal transduction systems in Alzheimer's disease. Ann N.Y. Acad. Sci. 695:1993;34-41
133. Scheff S.W., DeKosky S.T., Price D.A. Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol. Aging. 11:1990;29-37
134. Scheibel A.B., Tomiyasu U. Dendritic sprouting in Alzheimer's presenile dementia. Exp. Neurol. 60:1978;1-8
135. Schulman H. Protein phosphorylation in neuronal plasticity and gene expression. Curr. Opin. Neurobiol. 5:1995;375-381
136. Selkoe D.J. Normal and abnormal biology of the beta-amyloid precursor protein. Ann. Rev. Neurosci. 17:1994;489-517
137. Serrano M., Hannon G.J., Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 366:1993;704-707
138. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593-602
139. Seth A., Gonzalez F.A., Gupta S., Raden D.L., Davis R.J. Signal transduction within the nucleus by mitogen-activated protein kinase. J. Biol. Chem. 267:1992;24796-24804
140. Simchowicz T. Histologische Studien über die senile Demenz. Nissl F., Alzheimer A. Histologische Und Histopathologische Arbeiten Über Die Grosshirnrinde mit Besonderer Berücksichtigung der Pathologischen Anatomie Der Geisteskrankheiten. 1911;267-444 Fischer, Jena
141. Singer W. The brain as a self-organizing system. Eur. Arch. Psychiatr. Neurol. Sci. 236:1986;4-9
142. Smith M.Z., Nagy Z., Esiri M.M. Cell cycle-related protein expression in vascular dementia and Alzheimer's disease. Neurosci. Lett. 271:1999;45-48
143. Smith T.W., Lippa C.F. Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. J. Neuropathol. Exp. Neurol. 54:1995;297-303
144. Sontag E., Nunbhakdi-Craig V., Bloom G.S., Mumby M.C. A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J. Cell Biol. 128:1995;1131-1144
145. Spatz H. Anatomischer Befund eines Falles von präseniler Verblödung. Zentralbl. Neur. 40:1925;735
146. Stokoe D., MacDonald S.G., Cadwallader K., Symons M., Hancock J.F. Activation of Raf as a result of recruitment to the plasma membrane. Science. 264:1994;1463-1467
147. Storey E., Beyreuther K., Masters C.L. Alzheimer's disease amyloid precursor protein on the surface of cortical neurons in primary culture co-localizes with adhesion patch components. Brain Res. 735:1996;217-231
148. Suzuki T., Oishi M., Marshak D.R., Czernik A.J., Nairn A.C., Greengard P. Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBO J. 13:1994;1114-1122
149. Svennerholm L., Gottfries C.G. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J. Neurochem. 62:1994;1039-1047
150. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:1991;572-580
151. Terry R.D., Peck A., DeTeresa R., Schechter R., Horoupian D.S. Some morphometric aspects of the brain in senile dementia of the Alzheimer's type. Ann. Neurol. 10:1981;184-192
152. Thal D.R., Rub U., Schultz C., Sassin I., Ghebremedhin E., Del Tredici K., Braak E., Braak H. Sequence of Abeta-protein deposition in the human medical temporal lobe. Neuropathol. Exp. Neurol. 59:2000;733-748
153. Tokuda M., Hatase O. Regulation of neuronal plasticity in the central nervous system by phosphorylation and dephosphorylation. Mol. Neurobiol. 17:1998;137-156
154. Vincent I., Jicha G., Rosado M., Dickson D.W. Aberrant expression of mitogenic Cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J. Neurosci. 17:1997;3588-3598
155. Vincent I., Rosado M., Davies P. Mitogenic mechanisms in Alzheimer's disease? J. Cell Biol. 132:1996;413-425
156. Vincent I., Zheng J.H., Dickson D.W., Kress Y., Davies P. Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiol. Aging. 19:1998;287-296
157. Von Braunmühl A. Alterserkrankungen des Zentralnervensystems. Senile Involution. Senile Demenz. Alzheimersche Krankheit. Lubarsch O., Henke F., Rossle R. Handbuch Der Speziellen Pathologischen Anatomie und Histologie,. Vol. 13:1957;337-539 Springer-Verlag, Berlin
158. Wu W., Liuzzi F.J., Schinco F.P., Depto A.S., Li Y., Mong J.A., Dawson T.M., Snyder S.H. Neuronal nitric oxide synthase is induced in spinal neurons by traumatic injury. Neuroscience. 61:1994;719-726
159. Yardin C., Terro F., Esclaire F., Rigaud M., Hugon J. Brefeldin A-induced apoptosis is expressed in rat neurons with dephosphorylated tau protein. Neurosci. Lett. 250:1998;1-4
160. Yun H.Y., Gonzalez-Zulueta M., Dawson V.L., Dawson T.M. Nitric oxide mediates N-methyl-D-aspartate receptor-induced activation of p21 ras. Proc. Natl. Acad. Sci. USA. 95:1998;5773-5778
161. Zubenko G.S., Kopp U., Seto T., Firestone L.L. Platelet membrane fluidity individuals at risk for Alzheimer's disease: a comparison of results from fluorescence spectroscopy and electron spin resonance spectroscopy. Psychopharmacology (Berl.). 145:1999;175-180